리바노바 (LIVN) 주가

리바노바(LIVN)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $82.22 (+0.02%), 시가총액 $3.94B, PER 36.55, 52주 범위 $41.13 ~ $72.44.

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implan

핵심 지표

• 현재가: $82.22 (+0.02%)
• 시가총액: $3.94B
• PER (주가수익비율): 36.55
• 52주 최저~최고: $41.13 ~ $72.44
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

리바노바의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

리바노바 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.0909

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 3.17
• 순이익률: 0.07%
• 영업이익률: 0.14%

자주 묻는 질문